Walgreens Boots Alliance (NASDAQ: WBA) announced better-than-expected Q3 financial numbers. However, its stock closed almost 7% lower on Thursday. Multiple factors, including the year-over-year decline in sales and earnings, led investors to dump its stock.  Walgreens’ top line dropped 4.2% year-over-year as benefits from COVID-19 vaccinations continued to diminish. Moreover, management blamed the weakness in AllianceRx Walgreens for the overall decline in sales. While its revenues slipped, adjusted earnings fell over 30%, reflecting tough comparisons and growth investments.  Including yesterday’s decline, WBA stock has lost more than one-fourth of its value in 2022. Now What? Despite the weakness in Q3, Walgreens reiterated its EPS guidance and expects low-single-digit growth in FY22.
https://www.tipranks.com/news/article/heres-why-walgreens-stock-drops-7-despite-q3-beat?utm_source=advfn.com&utm_medium=referral
Walgreens Boots Alliance (NASDAQ:WBA)
Gráfico Histórico do Ativo
De Ago 2022 até Set 2022 Click aqui para mais gráficos Walgreens Boots Alliance.
Walgreens Boots Alliance (NASDAQ:WBA)
Gráfico Histórico do Ativo
De Set 2021 até Set 2022 Click aqui para mais gráficos Walgreens Boots Alliance.